A 184656
Alternative Names: A-184656Latest Information Update: 23 Jan 2013
At a glance
- Originator Abbott Laboratories
- Class Antibacterials; Ketolides
- Mechanism of Action Protein 50S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 31 Dec 2012 Discontinued - Preclinical for Bacterial infections in USA (unspecified route) before 2012
- 21 Apr 1999 Preclinical development for Bacterial infections in USA (Unknown route)